Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial
在接受 BNT162b2 COVID-19 疫苗初次接种后，接受积极治疗的实体瘤患者体内针对 SARS-CoV-2 的特异性体液和细胞免疫反应模式：来自 IV 期 CoVigi 试验的结果
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251316224
Obermannova, Radka Lordick; Selingerova, Iveta; Demlova, Regina; Okruhlicova, Dominika; Nevrlka, Jiri; Cerna-Pilatova, Katerina; Greplova, Kristina; Cermakova, Zdenka; Valik, Dalibor; Kiss, Igor; Palacova, Marketa; Poprach, Alexandr; Lejdarova, Hana; Selvekerova, Sarka; Vaneckova, Martina; Zdrazilova-Dubska, Lenka
